Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Valeant appoints Tyco's Sam Eldessouky corporate controller

Published 05/26/2016, 07:27 AM
Updated 05/26/2016, 07:30 AM
© Reuters. The headquarters of Valeant Pharmaceuticals International Inc. seen in Laval Quebec

(Reuters) - Embattled drugmaker Valeant Pharmaceuticals International Inc (N:VRX) appointed Sam Eldessouky senior vice president and corporate controller, effective May 31.

Eldessouky joins from security systems maker Tyco International Plc (N:TYC), where he has worked since 2004, most recently as senior vice president, controller and chief accounting officer.

© Reuters. The headquarters of Valeant Pharmaceuticals International Inc. seen in Laval Quebec

Valeant said in March that "improper conduct" by former Chief Financial Officer Howard Schiller and former Corporate Controller Tanya Carro had contributed to a misstatement of financial results.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.